Holen Sie sich die Stockscreener-App
2.01
6.35%
0.12
Handel nachbörslich:
2.05
0.04
+1.99%
Schlusskurs vom Vortag:
$1.89
Offen:
$1.91
24-Stunden-Volumen:
63,501
Relative Volume:
0.94
Marktkapitalisierung:
$8.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.88M
KGV:
-2.68
EPS:
-0.75
Netto-Cashflow:
$-25.20M
1W Leistung:
+24.07%
1M Leistung:
-6.07%
6M Leistung:
-53.76%
1J Leistung:
-78.39%
1-Tages-Spanne:
$1.88
$2.085
1-Wochen-Bereich:
$1.5603
$2.085
52-Wochen-Spanne:
$1.5301
$12.53
In 8 Bio Inc Stock (INAB) Company Profile
Firmenname
In 8 Bio Inc
Sektor
Branche
Telefon
(646) 600-6438
Adresse
EMPIRE STATE BUILDING, NEW YORK
Vergleichen Sie INAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INAB
In 8 Bio Inc
|
2.01 | 8.76M | 0 | -31.88M | -25.20M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
In 8 Bio Inc Stock (INAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-18 | Eingeleitet | Laidlaw | Buy |
| 2022-08-30 | Eingeleitet | H.C. Wainwright | Buy |
In 8 Bio Inc Aktie (INAB) Neueste Nachrichten
Risk Off: Will Passage Bio Inc. stock sustain high P E ratiosQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - BỘ NỘI VỤ
Can Korro Bio Inc. stock surprise with earnings upsideWeekly Profit Summary & Growth Focused Stock Pick Reports - BỘ NỘI VỤ
Nuvation Bio Inc Discontinues NUV-1511 Development - TradingView
Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire
Chmn Hoffman Buys 20,000 ($69.9K) Of Annovis Bio Inc [ANVS] - TradingView
Officer Hanley Sells 200,000 ($1.4M) Of Nuvation Bio Inc [NUVB] - TradingView
Officer Hattersley Files To Sell 369,051 Of Nuvation Bio Inc [NUVB] - TradingView
Officer Liu Files To Sell 20,000 Of Nuvation Bio Inc [NUVB] - TradingView
Officer Liu Sells 30,000 ($148K) Of Nuvation Bio Inc [NUVB] - TradingView
[Form 4] Inmune Bio, Inc. Insider Trading Activity - Stock Titan
[8-K] Inmune Bio, Inc. Reports Material Event | INMB SEC FilingForm 8-K - Stock Titan
Nuvation Bio Inc Publishes Positive Phase 2 Study Results for Safusidenib - TradingView
[8-K] TELA Bio, Inc. Reports Material Event | TELA SEC FilingForm 8-K - Stock Titan
Korro Bio, Inc. (KRRO): RBC Capital Initiates “Sector Perform” Rating with Upside Potential - Stocks Telegraph
[8-K] Instil Bio, Inc. Reports Material Event | TIL SEC FilingForm 8-K - Stock Titan
[8-K] Annovis Bio, Inc. Reports Material Event | ANVS SEC FilingForm 8-K - Stock Titan
[S-8] PALISADE BIO, INC. Employee Benefit Plan Registration | PALI SEC FilingForm S-8 - Stock Titan
[8-K] KALA BIO, Inc. Reports Material Event | KALA SEC FilingForm 8-K - Stock Titan
[Form 4] Annovis Bio, Inc. Insider Trading Activity - Stock Titan
Inmune Bio, Inc. Announces Key Developments in Clinical Programs - TradingView
[8-K] Passage BIO, Inc. Reports Material Event | PASG SEC FilingForm 8-K - Stock Titan
[8-K] Cabaletta Bio, Inc. Reports Material Event | CABA SEC FilingForm 8-K - Stock Titan
Belite Bio Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
KALA BIO Inc expected to post a loss of $1.45 a shareEarnings Preview - TradingView
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewswire Inc.
[8-K] Climb Bio, Inc. Reports Material Event | CLYM SEC FilingForm 8-K - Stock Titan
[8-K] Gossamer Bio, Inc. Reports Material Event | GOSS SEC FilingForm 8-K - Stock Titan
Gossamer Bio Inc reports results for the quarter ended September 30Earnings Summary - TradingView
[PRE 14A] Adicet Bio, Inc. Preliminary Proxy Statement - Stock Titan
[8-K] Adicet Bio, Inc. Reports Material Event | ACET SEC FilingForm 8-K - Stock Titan
[8-K] ImmunityBio, Inc. Reports Material Event | IBRX SEC FilingForm 8-K - Stock Titan
TELA Bio to Announce Third Quarter 2025 Financial Results - GlobeNewswire
Cabaletta Bio (Nasdaq: CABA) offers webcasts across Nov–Dec conferences; 30-day replays - Stock Titan
Gossamer Bio Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
[Form 4] TELA Bio, Inc. Insider Trading Activity - Stock Titan
[Form 3] TELA Bio, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Cabaletta Bio, Inc. (NASDAQ:CABA) Short Interest Up 85.8% in October - Defense World
[8-K] Protagenic Therapeutics, Inc.new Reports Material Event | PTIX SEC FilingForm 8-K - Stock Titan
Nuvation Bio Inc (NUVB) Q3 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Cabaletta Bio, Inc. Updates on Rese-cel Clinical Trials and FDA Alignment - TradingView
ANVS prices registered direct; directors buy 1.07M shares at $2.05 - Stock Titan
INMB to discuss Q3 2025 results on Oct 30, 4:30 p.m. ET - Stock Titan
Tourmaline Bio Announces Board and Executive Resignations Following Merger - TradingView
[8-K] Tourmaline Bio, Inc. Reports Material Event | TRML SEC FilingForm 8-K - Stock Titan
Why Nuvation Bio Inc. stock is a must watch in 2025Trade Entry Report & Long-Term Safe Investment Ideas - fcp.pa.gov.br
Cabaletta Bio, Inc. Presents Clinical Data and Updates at ACR Convergence 2025 - TradingView
INmune Bio (NASDAQ: INMB) schedules results call for 4:30 PM ET on Oct 30 - Stock Titan
[8-K] PALISADE BIO, INC. Reports Material Event | PALI SEC FilingForm 8-K - Stock Titan
Q32 Bio Inc Completes Enrollment in SIGNAL-AA Phase 2a Trial - TradingView
[8-K] bioAffinity Technologies, Inc. Reports Material Event | BIAF SEC FilingForm 8-K - Stock Titan
PALI annual meeting: directors elected, auditor ratified, split approved - Stock Titan
Finanzdaten der In 8 Bio Inc-Aktie (INAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
2.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):